ASX/CU6 (ASX/CU6)

Australian Securities Exchange: ASX/CU6 · AUD

A$1.57

+0.02 (+1.0%)· Recorded snapshot

Market cap	583.9M
Revenue (ttm)	10.5M
Net income (ttm)	-107.2M
EPS (ttm)	-A$0.29
Shares out	373.1M
Volume	4,140,307
Beta	1.18

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 10.5M
Net income (ttm): -107.2M
EPS (ttm): -A$0.29
Market cap: 583.9M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-77.5

P25 n/aP50 n/aP75 n/a

ROIC-49

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ASX/CU6 indicators

Market & fundamental data

Available fields

180

Groups with data

Currency

AUD

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-11-26
Employees	100
Employees change	31
Employees growth	44.93%
Enterprise value	AUD 405.6M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	2010
Industry	Biotechnology
Is primary listing	Yes
ISIN number	AU0000165375
Last earnings date	2026-02-26
Last refreshed	2026-10-28
Market cap	AUD 583.9M
Next earnings date	2026-11-26
Price	AUD 1.57
Price currency	AUD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	asx/CU6
Website	https://www.claritypharmaceuticals.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-18.62%
EV/Sales	38.53x
FCF / EV yield	-22.89%
FCF yield	-15.9%
Industry forward P/E	28.51x
P/B ratio	3.14x
P/S ratio	55.47x
Price / tangible book value	3.14x
Sector forward P/E	33.76x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Operating margin	-1,029.61%
Pretax margin	-1,009.68%
Profit per employee	AUD -1.1M
Revenue per employee	AUD 105,263
ROA	-45.12%
ROA (5Y)	-27.76%
ROCE	-58.04%
ROE	-77.54%
ROE (5Y)	-48.78%
ROIC	-49.02%
SBC / revenue	96.05%
Tax / revenue	8.18%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Gross profit growth	11.24%
Gross profit growth (Q)	-1.12%
Gross profit growth 3Y	2.41%
Gross profit growth 5Y	26.92%
Net income growth years	0
Revenue growth	11.24%
Revenue growth (Q)	-1.12%
Revenue growth (QoQ)	-18.68%
Revenue growth 3Y	2.41%
Revenue growth 5Y	26.92%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -306,922
Depreciation and amortization	AUD 283,530
EBIT	AUD -108.4M
EBITDA	AUD -108.1M
EPS	AUD -0.29
FCF per share	AUD -0.25
Financing cash flow	AUD 193M
Free cash flow	AUD -92.9M
Free cash flow minus SBC	AUD -103M
Gross profit	AUD 10.5M
Income taxes	AUD 860,559
Investing cash flow	AUD -84.9M
Net cash flow	AUD 9.5M
Net income	AUD -107.2M
Operating cash flow minus SBC	AUD -102.7M
Operating income	AUD -108.4M
Revenue	AUD 10.5M
Stock-based compensation	AUD 10.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	55.9
Book value per share	AUD 0.50
Debt / equity	0
Long-term assets	AUD 579,417
Long-term liabilities	AUD 618,354
Net cash (debt)	AUD 178.3M
Net cash / market cap	30.53%
Net cash growth	111.91%
Net debt / equity	-0.96
Piotroski F-Score	2
Property, plant and equipment	AUD 565,603
Shareholders' equity	AUD 186.1M
Tangible book value	AUD 186.1M
Tangible book value per share	AUD 0.50
Total assets	AUD 199.1M
Total cash	AUD 178.3M
Total debt	AUD 0
Total liabilities	AUD 13M
WACC	10.74%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.07
Current assets	AUD 198.5M
Current liabilities	AUD 12.3M
Current ratio	16.09
Net working capital	AUD 7.9M
Quick ratio	15.49
Working capital	AUD 186.1M
Working capital turnover	0.08

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-15.3%
Shareholder yield	-15.3%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	AUD 2.42
1D price change	0.97%
1M price change	-25.83%
1M total return	-25.83%
1W price change	-11.58%
1W total return	-11.58%
1Y price change	-65.38%
1Y return CAGR	-65.4%
1Y total return	-65.38%
20-day SMA	AUD 1.82
200-day SMA	AUD 2.65
3M price change	-29.82%
3M total return	-29.82%
3Y price change	49.05%
3Y return CAGR	14.34%
3Y total return	49.51%
50-day SMA	AUD 2.09
50-day SMA vs 200-day SMA	50under200
52-week high	AUD 5.14
52-week high date	2025-10-31
52-week low	AUD 1.52
52-week low date	2026-10-23
5Y price change	43.58%
5Y return CAGR	7.57%
5Y total return	44.02%
6M price change	-49.68%
6M total return	-49.68%
All-time high	AUD 8.98
All-time high date	2024-09-23
All-time low	AUD 0.36
All-time low date	2022-06-23
Average true range (ATR)	AUD 0.11
Average volume	3M
Beta (1Y)	0.96
Beta (2Y)	1.41
Beta (5Y)	1.18
Change from 52-week high	-69.55%
Change from 52-week low	3.3%
Change from all-time high	-82.56%
Change from all-time low	334.72%
Change from open	0.64%
Day's gap	0.32%
Dollar volume	AUD 6.5M
High price	AUD 1.61
Low price	AUD 1.54
Monthly RSI	40.02
Open price	AUD 1.56
Position in 52-week range	37.31%
Previous close	AUD 1.55
Price vs 150-day SMA	-35.41%
Price vs 20-day SMA	-14.2%
Price vs 200-day SMA	-41.01%
Price vs 50-day SMA	-24.94%
Relative volume	1.4
RSI	29.2
Sharpe ratio	-1.09
Sharpe ratio (3Y)	0.52
Sharpe ratio (5Y)	0.39
Sortino ratio	-1.59
Sortino ratio (3Y)	0.9
Sortino ratio (5Y)	0.7
Volume	4.1M
Weekly RSI	29.3
YTD price change	-53.7%
YTD total return	-53.7%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	288.8M
Shares change (QoQ)	2.33%
Shares change (YoY)	15.3%
Shares held by insiders	13.16%
Shares held by institutions	30.78%
Shares outstanding	373.1M

Deeper analysis on ASX/CU6

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/CU6 report

Is a complete ASX/CU6 research report available?

No complete published report is available for asx/CU6 (ASX/CU6) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/CU6 (ASX/CU6)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/CU6

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/CU6 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/CU6

Frequently asked questions